David Happel serves as Executive at Raptor Pharmaceutical Corp, where they oversee executive responsibilities. Since joining the company, David Happel has executed 12 insider transactions totaling $669.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 21, 2025 involved selling 65,478 shares valued at $597.8K.
David Happel currently holds 689,722 shares of Raptor Pharmaceutical Corp (RPTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Happel has been a net seller of RPTP stock. They have purchased $71.7K and sold $597.8K worth of shares.
David Happel's most recent insider trade was on Jul 21, 2025, when they sold 65,478 shares at $9.13 per share.
Get notified when new Form 4 filings are submitted
| $5.27 |
| Discretionary |
| Dec 7, 2023 | SGMT | $6.6K | Purchase | 1,600 | $4.10 | Discretionary |
| Nov 17, 2023 | SGMT | $0 | Award | 624,910 | $N/A | Discretionary |
| Nov 16, 2023 | SGMT | $1.4K | Purchase | 590 | $2.35 | Discretionary |
| Oct 25, 2017 | HZNP | $56.1K | Payment | 4,150 | $13.53 | Discretionary |
| Oct 25, 2017 | HZNP | $0 | Option Exercise | 7,953 | $N/A | Discretionary |
| Oct 25, 2016 | RPTP | $260.5K | Disposition | 28,939 | $9.00 | Discretionary |
| Oct 24, 2016 | RPTP | $80.4K | Tender | 8,934 | $9.00 | Discretionary |
| Mar 1, 2016 | RPTP | $2.0K | Payment | 576 | $3.43 | Discretionary |
| Feb 9, 2016 | RPTP | $0 | Award | 25,017 | $N/A | Discretionary |
| Feb 9, 2015 | RPTP | $0 | Award | 5,229 | $N/A | Discretionary |